India's Biocon Limited, signed a semi-exclusive partnership agreement with Zentiva, a leading pharmaceutical company in Europe, for the commercialization of its vertically integrated, complex formulation, Liraglutide, a drug-device combination for the treatment and management of Type 2 diabetes and obesity. Under the terms of this agreement, Biocon will be responsible...
Huntsman India Sales Cross $500 million
Peter R. Huntsman, President and Chief Executive of the $12 billion chemicals maker, Huntsman Corporation, inaugurated a new India corporate office in Mumbai on November 4, 2014. Initially, the 220,000 square feet, seven story building will house about 300 Huntsman associates, including over 100 technical staff spread across three floors...